The street value of gabapentin is not readily available through publicly disclosed sales data, as it is a prescription medication. Illicit sales are not tracked in official markets.
How is Gabapentin Typically Prescribed?
Gabapentin is a medication prescribed for treating epilepsy and neuropathic pain [1]. It works by affecting chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. It is also sometimes used to treat restless legs syndrome [2].
Are There Concerns About Gabapentin Misuse?
Gabapentin has been identified as a drug of concern for misuse and abuse, often in combination with other substances like opioids [3]. Regulatory bodies and healthcare professionals have noted an increase in its diversion and non-medical use, which can lead to dependence and significant health risks [4]. The U.S. Drug Enforcement Administration (DEA) has highlighted gabapentin's role in drug overdose deaths, particularly when mixed with opioids [3].
What are the Risks of Using Gabapentin Illicitly?
Illicit use of gabapentin carries significant risks. These can include respiratory depression, especially when combined with other central nervous system depressants, and the potential for dependence and withdrawal symptoms [4]. The U.S. Food and Drug Administration (FDA) has warned about the serious breathing problems that can occur with gabapentin use, particularly in patients with underlying respiratory conditions or those taking opioid medications [5].
How is Gabapentin Regulated?
Gabapentin is a controlled substance in some jurisdictions due to its potential for misuse. For instance, it is classified as a Schedule V controlled substance in New York [6]. This classification subjects it to specific regulations regarding prescribing, dispensing, and record-keeping.
Where Can I Find Information on Drug Patents?
For detailed information on drug patents, including their expiration dates and any associated litigation, resources like DrugPatentWatch.com are available [7].
Sources:
[1] https://www.nhs.uk/medicines/gabapentin/
[2] https://www.webmd.com/drugs/2/drug-12400/gabapentin-oral/details
[3] https://www.dea.gov/sites/default/files/2020-07/DEA%20Gabapentin%20Overview.pdf
[4] https://www.samhsa.gov/resource/ebp/gabapentin-emerging-concerns-misuse-and-abuse
[5] https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-not-using-neurontin-gabapentin-enacarbil-and-horizant
[6] https://www.governor.ny.gov/news/governor-cuomo-announces-new-york-first-state-nation-requiring-prescriptions-gabapentin
[7] https://drugpatentwatch.com/